Gastroenterology
Volume 129, Issue 6 , Pages 1825-1831 , December 2005

Prevalence of Barrett’s Esophagus in the General Population: An Endoscopic Study

  • Jukka Ronkainen

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden
    • Primary Health Care Center, Keminmaa, Finland
    • Corresponding Author InformationAddress requests for reprints to: Jukka Ronkainen, MD, Primary Health Care Center, Väylätie 2, Keminmaa SF-94400, Finland. fax: (358) 16-227165.
    • ,
  • Pertti Aro

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Tom Storskrubb

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden
    • Department of Medicine, Kalix Hospital, Kalix, Sweden
    • ,
  • Sven–Erik Johansson

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Tore Lind

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • ,
  • Elisabeth Bolling–Sternevald

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden
    • AstraZeneca R&D, Mölndal, Sweden
    • ,
  • Michael Vieth

      Affiliations

    • Institute of Pathology, Bayreuth, Germany
    • ,
  • Manfred Stolte

      Affiliations

    • Institute of Pathology, Bayreuth, Germany
    • ,
  • Nicholas J. Talley

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota
    • Department of Medicine, University of Sydney, Sydney, Australia
    • ,
  • Lars Agréus

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden

Received 5 May 2005 ,Accepted 17 August 2005.

References 

  1. Spechler SJ . The columnar-lined esophagus. History, terminology, and clinical issues . Gastroenterol Clin North Am . 1997;26:455–466
  2. Hirota WK , Loughney TM , Lazas DJ , Maydonovitch CL , Rholl V , Wong RK . Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction (prevalence and clinical data) . Gastroenterology . 1999;116:277–285
  3. Sampliner RE . Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus . Am J Gastroenterol . 2002;97:1888–1895
  4. Falk GW . Gastroesophageal reflux disease and Barrett’s esophagus . Endoscopy . 2001;33:109–118
  5. Falk GW . Barrett’s esophagus . Gastroenterology . 2002;122:1569–1591
  6. O’Connor JB , Falk GW , Richter JE . The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus (report on the Cleveland Clinic Barrett’s Esophagus Registry) . Am J Gastroenterol . 1999;94:2037–2042
  7. Shaheen NJ , Crosby MA , Bozymski EM , Sandler RS . Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? . Gastroenterology . 2000;119:333–338
  8. Spechler SJ . Clinical practice. Barrett’s Esophagus . N Engl J Med . 2002;346:836–842
  9. Jankowski JA , Provenzale D , Moayyedi P . Esophageal adenocarcinoma arising from Barrett’s metaplasia has regional variations in the west . Gastroenterology . 2002;122:588–590
  10. Blot WJ , Devesa SS , Kneller RW , Fraumeni JF . Rising incidence of adenocarcinoma of the esophagus and gastric cardia . JAMA . 1991;265:1287–1289
  11. Haggitt RC . Adenocarcinoma in Barrett’s esophagus (a new epidemic?) . Hum Pathol . 1992;23:475–476
  12. Devesa SS , Blot WJ , Fraumeni JF . Changing patterns in the incidence of esophageal and gastric carcinoma in the United States . Cancer . 1998;83:2049–2053
  13. Bytzer P , Christensen PB , Damkier P , Vinding K , Seersholm N . Adenocarcinoma of the esophagus and Barrett’s esophagus (a population-based study) . Am J Gastroenterol . 1999;94:86–91
  14. Cameron AJ , Zinsmeister AR , Ballard DJ , Carney JA . Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings . Gastroenterology . 1990;99:918–922
  15. Voutilainen M , Sipponen P , Mecklin JP , Juhola M , Farkkila M . Gastroesophageal reflux disease (prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms) . Digestion . 2000;61:6–13
  16. Malfertheiner P, Lind T, Willich S, Vieth M, Jaspersen D, Labenz J, et al. Prognostic influence of Barrett’s oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal (GORD) and symptom resolution in non-erosive GORD (report from the ProGORD Study) . Gut . 2005;54:746–751
  17. Gerson LB , Shetler K , Triadafilopoulos G . Prevalence of Barrett’s esophagus in asymptomatic individuals . Gastroenterology . 2002;123:461–467.
  18. Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RK, Vasudeva RS, et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn . Gastroenterology . 2003;125:1670–1677
  19. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson SE, et al. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population (the Kalixanda study) . Scand J Gastroenterol . 2004;39:1280–1288
  20. Agréus L , Svärdsudd K , Nyrén O , Tibblin G . Reproducibility and validity of a postal questionnaire. The abdominal symptom study . Scand J Prim Health Care . 1993;11:252–262
  21. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Svardsudd K, Talley NJ, et al. Validation of the translation and cross-cultural adaptation into Finnish of the Abdominal Symptom Questionnaire, the Hospital Anxiety and Depression Scale and the Complaint Score Questionnaire . Scand J Gastroenterol . 2004;39:1201–1208
  22. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population (a Kalixanda study report) . Scand J Gastroenterol . 2005;40:275–285
  23. Wallner B , Sylvan A , Stenling R , Janunger KG . The esophageal Z-line appearance correlates to the prevalence of intestinal metaplasia . Scand J Gastroenterol . 2000;35:17–22
  24. Spechler SJ . Columnar-lined esophagus. Definitions . Chest Surg Clin North Am . 2002;12:1–13 vii
  25. McClave SA , Boyce HW , Gottfried MR . Early diagnosis of columnar-lined esophagus (a new endoscopic diagnostic criterion) . Gastrointest Endosc . 1987;33:413–416
  26. Gottfried MR , McClave SA , Boyce HW . Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett’s esophagus) . Am J Clin Pathol . 1989;92:741–746
  27. Lieberman D , Fennerty MB , Morris CD , Holub J , Eisen G , Sonnenberg A . Endoscopic evaluation of patients with dyspepsia (results from the national endoscopic data repository) . Gastroenterology . 2004;127:1067–1075
  28. Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis (a progress report on observer agreement) . Gastroenterology . 1996;111:85–92
  29. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis (clinical and functional correlates and further validation of the Los Angeles classification) . Gut . 1999;45:172–180
  30. Klauser AG , Schindlbeck NE , Müller-Lissner SA . Symptoms in gastro-oesophageal reflux disease . Lancet . 1990;335:205–208
  31. Dixon MF , Genta RM , Yardley JH , Correa P . Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 . Am J Surg Pathol . 1996;20:1161–1181
  32. Voutilainen M , Farkkila M , Juhola M , Mecklin JP , Sipponen P . Complete and incomplete intestinal metaplasia at the oesophagogastric junction (prevalences and associations with endoscopic erosive oesophagitis and gastritis) . Gut . 1999;45:644–648
  33. Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, et al. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection (a report on histology and H. pylori detection in the general adult population) . Scand J Gastroenterol . 2005;40:302–311
  34. Kleinbaum DG . In: Logistic regression (a self-learning text) . 2nd ed.. New York, NY: Springer Verlag; 2002;
  35. Stata. Corp . Stata statistical software (release 8.0) . College Station, TX: Stata Corp; 2003;
  36. World Health Organization . Obesity (preventing and managing the global epidemic) . WHO Technical Report Series, No. 894 . Geneva, Switzerland: World Health Organization; 1997;
  37. Armstrong D . Review article (towards consistency in the endoscopic diagnosis of Barrett’s oesophagus and columnar metaplasia) . Aliment Pharmacol Ther . 2004;20(Suppl 5):40–47 discussion 61–62
  38. Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, et al. A critical review of the diagnosis and management of Barrett’s esophagus (the AGA Chicago Workshop) . Gastroenterology . 2004;127:310–330
  39. Cameron AJ . Barrett’s esophagus (prevalence and size of hiatal hernia) . Am J Gastroenterol . 1999;94:2054–2059
  40. Avidan B , Sonnenberg A , Schnell TG , Chejfec G , Metz A , Sontag SJ . Hiatal hernia size, Barrett’s length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma . Am J Gastroenterol . 2002;97:1930–1936
  41. Conio M, Filiberti R, Blanchi S, Ferraris R, Marchi S, Ravelli P, et al. Risk factors for Barrett’s esophagus (a case-control study) . Int J Cancer . 2002;97:225–229
  42. Kulig M, Nocon M, Vieth M, Leodolter A, Jaspersen D, Labenz J, et al. Risk factors of gastroesophageal reflux disease (methodology and first epidemiological results of the ProGERD study) . J Clin Epidemiol . 2004;57:580–589
  43. Gerson LB , Edson R , Lavori PW , Triadafilopoulos G . Use of a simple symptom questionnaire to predict Barrett’s esophagus in patients with symptoms of gastroesophageal reflux . Am J Gastroenterol . 2001;96:2005–2012
  44. Lagergren J , Bergström R , Lindgren A , Nyrén O . Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma . N Engl J Med . 1999;340:825–831
  45. Drewitz DJ , Sampliner RE , Garewal HS . The incidence of adenocarcinoma in Barrett’s esophagus (a prospective study of 170 patients followed 4.8 years) . Am J Gastroenterol . 1997;92:212–215
  46. Hage M , Siersema PD , van Dekken H , Steyerberg EW , Dees J , Kuipers EJ . Oesophageal cancer incidence and mortality in patients with long-segment Barrett’s oesophagus after a mean follow-up of 12.7 years . Scand J Gastroenterol . 2004;39:1175–1179
  47. Funkhouser EM , Sharp GB . Aspirin and reduced risk of esophageal carcinoma . Cancer . 1995;76:1116–1119
  48. Corley DA , Kerlikowske K , Verma R , Buffler P . Protective association of aspirin/NSAIDs and esophageal cancer (a systematic review and meta-analysis) . Gastroenterology . 2003;124:47–56

 Supported in part by the Swedish Research Council, the Swedish Society of Medicine, Mag-tarm sjukas förbund, Norrbotten County Council (Sweden), and AstraZeneca R&D (Sweden).

PII: S0016-5085(05)01771-3

doi: 10.1053/j.gastro.2005.08.053

Gastroenterology
Volume 129, Issue 6 , Pages 1825-1831 , December 2005

Article Tools